methamphetamine has been researched along with olanzapine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kofoed, L; Misra, LK; Oesterheld, JR; Richards, GA | 1 |
| He, J; Li, XM; Xu, H; Yang, Y; Zhang, X | 1 |
| Inada, T; Oda, T; Yamamoto, N | 1 |
| Abekawa, T; Ito, K; Koyama, T; Nakagawa, S; Nakato, Y | 1 |
| Correll, CU; Iwata, N; Kishi, T; Matsuda, Y | 1 |
| Habata, Y; Imaichi, S; Komatsu, H; Maruyama, M; Mori, M; Sakuma, K | 1 |
| Aguilera, L; García, JM; Iriondo, O; Rodríguez, T; Zaldibar-Gerrikagoitia, J | 1 |
| Castle, DJ; Chan, EW; Karro, J; Knott, JC; Kong, DCM; Phillips, GA; Taylor, DM; Taylor, SE; Yap, CYL | 1 |
| Capuani, C; Corsi, M; Harada, A; Kimura, H; Suzuki, H; Suzuki, K; Ugolini, A | 1 |
| Likhitsathian, S; Maneeton, B; Maneeton, N; Oon-Arom, A; Srisurapanont, M; Suradom, C; Suttajit, S | 1 |
| Balogun, OD; Bolton, J; Casidsid, HJM; Chartier, M; Dragan, R; Enns, JE; Freier, A; Hinds, A; Konrad, G; McCulloch, SC; McDonald, N; Mignone, J; Mulhall, D; Nickel, NC; Phillips-Beck, W; Sanguins, J; Sarkar, J; Shimmin, C | 1 |
| Li, K; Liu, X; Su, R; Zhang, M | 1 |
3 review(s) available for methamphetamine and olanzapine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Topics: Amphetamine-Related Disorders; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Olanzapine; Outcome Assessment, Health Care; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Substance Withdrawal Syndrome; Synaptic Transmission; Treatment Outcome | 2013 |
Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Methamphetamine; Network Meta-Analysis; Olanzapine; Patient Dropouts; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2021 |
1 trial(s) available for methamphetamine and olanzapine
| Article | Year |
|---|---|
Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Akathisia, Drug-Induced; Australia; Benzodiazepines; Dopamine D2 Receptor Antagonists; Double-Blind Method; Droperidol; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Injections, Intravenous; Male; Methamphetamine; Midazolam; Middle Aged; Olanzapine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2017 |
12 other study(ies) available for methamphetamine and olanzapine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Olanzapine treatment of methamphetamine psychosis.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Central Nervous System Stimulants; Humans; Male; Methamphetamine; Olanzapine; Pirenzepine; Psychoses, Substance-Induced; Risperidone | 2000 |
Neuroprotective effects of olanzapine on methamphetamine-induced neurotoxicity are associated with an inhibition of hyperthermia and prevention of Bcl-2 decrease in rats.
Topics: Analysis of Variance; Animals; Apoptosis; Benzodiazepines; Brain Diseases; Dopamine; Fever; Immunohistochemistry; Male; Methamphetamine; Neostriatum; Neuroprotective Agents; Neurotoxins; Olanzapine; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Survival Rate; Tyrosine 3-Monooxygenase | 2004 |
Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
Topics: Aged; Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Biperiden; Central Nervous System Stimulants; Clonazepam; Dyskinesia, Drug-Induced; Hallucinations; Haloperidol; Humans; Male; Methamphetamine; Olanzapine; Posture; Psychoses, Substance-Induced; Risperidone | 2007 |
Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex.
Topics: Animals; Antipsychotic Agents; Apoptosis; Behavior, Animal; Benzodiazepines; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; In Situ Nick-End Labeling; Male; Methamphetamine; Motor Activity; Neural Inhibition; Neuroprotective Agents; Olanzapine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Time Factors | 2008 |
Temporal and spatial transcriptional fingerprints by antipsychotic or propsychotic drugs in mouse brain.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Dizocilpine Maleate; Gene Expression Profiling; Gene Expression Regulation; Hallucinogens; Haloperidol; Methamphetamine; Mice; Olanzapine; Phencyclidine; Receptors, Dopamine D2 | 2015 |
Anti-NMDA (a-NMDAR) receptor encephalitis related to acute consumption of metamphetamine: Relevance of differential diagnosis.
Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Anticonvulsants; Autoantibodies; Benzodiazepines; Catatonia; Delayed Diagnosis; Diagnosis, Differential; Diagnostic Errors; Diazepam; Electroconvulsive Therapy; Emergencies; Epilepsies, Partial; Hallucinations; Humans; Infectious Encephalitis; Male; Methamphetamine; Olanzapine; Poisoning; Receptors, N-Methyl-D-Aspartate; Status Epilepticus; Young Adult | 2017 |
Combined treatment with a selective PDE10A inhibitor TAK-063 and either haloperidol or olanzapine at subeffective doses produces potent antipsychotic-like effects without affecting plasma prolactin levels and cataleptic responses in rodents.
Topics: Administration, Oral; Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Benzodiazepines; Catalepsy; Corpus Striatum; Dendritic Spines; Disease Models, Animal; Dopamine Antagonists; Drug Synergism; Drug Therapy, Combination; Haloperidol; Humans; Male; Methamphetamine; Mice; Mice, Inbred ICR; Neurons; Olanzapine; Phosphodiesterase Inhibitors; Prolactin; Pyrazoles; Pyridazines; Rats; Rats, Sprague-Dawley; Synaptic Potentials; Treatment Outcome | 2018 |
Characterising methamphetamine use to inform health and social policies in Manitoba, Canada: a protocol for a retrospective cohort study using linked administrative data.
Topics: Canada; Cohort Studies; Humans; Manitoba; Methamphetamine; Olanzapine; Public Policy; Retrospective Studies | 2022 |
Effects of Ketanserin, M100907 and Olanzapine on hallucinogenic like action induced by 2,5-dimethoxy-4-methylamphetamine.
Topics: Animals; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Ketanserin; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Olanzapine; Receptor, Serotonin, 5-HT2A | 2023 |